Chinese herbal medicine combined with cognitive-behavioural therapy for avoidant paruresis: a controlled trial

被引:0
作者
Liang, Shijie [1 ]
Zhou, Ying [2 ]
Yu, Chao [1 ,3 ]
Gao, Xiang [3 ,4 ]
Ji, Fangbin [4 ]
Fang, Qianyuan [1 ]
Zhang, Zhihang [1 ]
Yang, Libin [1 ]
Zhao, Youkang [1 ]
Zhao, Yuhui [1 ]
Yin, Renwu [1 ]
Chen, Kaimin [1 ]
Lu, Zheng [5 ,6 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Urol, Shanghai, Peoples R China
[2] Mental Hlth Ctr Huangpu, Psychol, Shanghai, Peoples R China
[3] Inst Huada Appl Psychol, Med Counseling Dept, Shanghai, Peoples R China
[4] Lehu Psychol Consulting Co LTD, Psychol Counseling Dept, Shanghai, Peoples R China
[5] Tongji Univ, Sch Med, Dept Psychiat, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China
关键词
cognitive behavioral therapy;
D O I
10.1136/gpsych-2023-101014
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Avoidant paruresis is a common clinical condition in urology and psychosomatic medicine. However, it has limited treatment options that are safe and effective with few side effects.Aims Our study aimed to investigate the effectiveness and safety of the Chinese herbal Yangxin Tongquan decoction combined with cognitive-behavioural therapy (CBT) for avoidant paruresis.Methods Sixty-eight patients with avoidant paruresis were divided into a treatment group (33 patients) and a control group (35 patients). The control group was assigned 10 weeks of CBT and systematic desensitisation. In addition to CBT and systematic desensitisation, the treatment group was given the Chinese herbal Yangxin Tongquan decoction during the 10-week study. The Shy Bladder Syndrome Scale (SBS) and the Self-rating Anxiety Scale (SAS) were administered before and after treatment to measure any change.Results The overall efficacy in the treatment group (n=30) was 80.0% vs 62.5% in the control group (n=33). Comparing pretreatment and post-treatment measures, both groups showed improvement in SBS scores and SAS scores (treatment group: t((SBS)) =8.397, p((SBS)) <0.001, t((SAS)) =8.216, p((SAS))<0.001; control group: t((SBS)) =6.802, p((SBS)) <0.001, t((SAS))=5.171, p((SAS)) <0.001). Moreover, both groups' SBS and SAS scores changed significantly over time (SBS scores: F-time =118.299, p<0.001; SAS scores: F-time =92.114, p<0.001). However, the treatment group performed better than the control group (SBS scores: F-time*group =5.709, p=0.020; SAS scores: F-time*group =7.235, p=0.009).Conclusions The Chinese herbal Yangxin Tongquan decoction combined with cognitive-behavioural psychotherapy positively affects the treatment of avoidant paruresis without significant adverse effects.
引用
收藏
页数:8
相关论文
共 50 条
[31]   Cognitive behavior therapy for driving fear: A pilot randomized controlled trial [J].
Fischer, Carolin ;
Heider, Jens ;
Taylor, Joanne E. ;
Schroeder, Annette .
TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR, 2021, 83 :118-129
[32]   A Culturally Adapted Cognitive Behavioral Therapy Group: A Randomized Controlled Trial [J].
Young, Daniel K. W. ;
Yat-nam, Petrus N. G. .
RESEARCH ON SOCIAL WORK PRACTICE, 2022, 32 (04) :415-425
[33]   A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD [J].
Hynninen, Minna J. ;
Bjerke, Nina ;
Pallesen, Stale ;
Bakke, Per S. ;
Nordhus, Inger Hilde .
RESPIRATORY MEDICINE, 2010, 104 (07) :986-994
[34]   Cognitive behavioral therapy for depressed older outpatients - A controlled, randomized trial [J].
Hautzinger, M ;
Welz, S .
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2004, 37 (06) :427-435
[35]   A Randomized Controlled Trial of Cognitive Behavioral Group Therapy for Bipolar Disorder [J].
Gomes, B. C. ;
Abreu, L. N. ;
Brietzke, E. ;
Caetano, S. C. ;
Kleinman, A. ;
Nery, F. G. ;
Lafer, B. .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2011, 80 (03) :144-150
[36]   A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence [J].
Petitjean, Sylvie A. ;
Duersteler-MacFarland, Kenneth M. ;
Krokar, Marina Croquette ;
Strasser, Johannes ;
Mueller, Sandra E. ;
Degen, Bigna ;
Trombini, Mauro V. ;
Vogel, Marc ;
Walter, Marc ;
Wiesbeck, Gerhard A. ;
Farronato, Nadine S. .
DRUG AND ALCOHOL DEPENDENCE, 2014, 145 :94-100
[37]   Cognitive-Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder: Secondary Outcomes of a Randomized Controlled Trial [J].
Grilo, Carlos M. ;
Ivezaj, Valentina ;
Yurkow, Sydney ;
Tek, Cenk ;
Gueorguieva, Ralitza .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2025,
[38]   Behavioral couples therapy versus cognitive behavioral therapy for problem gambling: a randomized controlled trial [J].
Nilsson, Anders ;
Magnusson, Kristoffer ;
Carlbring, Per ;
Andersson, Gerhard ;
Hellner, Clara .
ADDICTION, 2020, 115 (07) :1330-1342
[39]   Cognitive Behavioral Therapy for Insomnia in Posttraumatic Stress Disorder: A Randomized Controlled Trial [J].
Talbot, Lisa S. ;
Maguen, Shira ;
Metzler, Thomas J. ;
Schmitz, Martha ;
McCaslin, Shannon E. ;
Richards, Anne ;
Perlis, Michael L. ;
Posner, Donn A. ;
Weiss, Brandon ;
Ruoff, Leslie ;
Varbel, Jonathan ;
Neylan, Thomas C. .
SLEEP, 2014, 37 (02) :327-341
[40]   Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial [J].
Moonen, Anja J. H. ;
Mulders, Anne E. P. ;
Defebvre, Luc ;
Duits, Annelien ;
Flinois, Berengere ;
Kohler, Sebastian ;
Kuijf, Mark L. ;
Leterme, Anne-Claire ;
Servant, Dominique ;
de Vugt, Marjolein ;
Dujardin, Kathy ;
Leentjens, Albert F. G. .
MOVEMENT DISORDERS, 2021, 36 (11) :2539-2548